Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
NKTR

Updated 10/6/2026, 9:41 AM ET.

NKTR

NEKTAR THERAPEUTICS

Sale$13,388

Zalevsky Jonathan

Chief R&D Officer

186 shat $71.98Filed Aug 20, 7:05 PM ETFiling
NKTR

NEKTAR THERAPEUTICS

Sale$30,088

ROBIN HOWARD W

President & CEO, Director

418 shat $71.98Filed Aug 20, 7:03 PM ETFiling

Read from public SEC filings. Not financial advice.